menu search

Fincom approves vida markets' membership, withdraws idealfx’s

The Financial Commission (FinCom), the independent external dispute resolution (EDR) body for the forex industry, has...

January 12, 2023, 4:39 pm

Roche (rhhby) gets eu approval for xofluza in new patient base

The European Commission approves Roche's (RHHBY) Xofluza for treating uncomplicated influenza and post-...

January 12, 2023, 2:18 pm

Samsung asset management to launch a bitcoin futures etf in hong kong

(Kitco News) - Samsung Asset Management Hong Kong (SAMHK) has been approved to list the “Samsung Bitc...

January 12, 2023, 12:17 pm

El salvador passes key bitcoin legislation, making way for ‘volcano bonds’

El Salvador’s legislative assembly has approved a digital securities bill that also paves the way for...

January 12, 2023, 11:14 am

El salvador legislators pass law allowing bitcoin bond sales

Lawmakers approved legislation that aims to facilitate the raising of funds tied to the value of the cr...

January 12, 2023, 1:14 am

El salvador passes law allowing bitcoin bond issuance

El Salvador’s congress approved a digital securities law that would allow the nation to raise funds t...

January 12, 2023, 1:14 am

Binance's new swedish registration marks 7th regulatory license in eu

Binance Nordics AB, the Swedish subsidiary of top cryptocurrency exchagne, Binance, has been registered as a virtual currency tra...

January 11, 2023, 5:19 pm

Palomar (pmr) debuts in crop insurance with advanced agprotection

Palomar's (PLMR) long-term fronting arrangement with Advanced AgProtection makes it the 14th approved i...

January 11, 2023, 12:48 pm

Victoria’s secret & co. announces new share repurchase authorization and provides fourth quarter 2022 sales and earnings update

Announces New $250 Million Share Repurchase Authorization Expects Fourth Quarter 2022 Net Sales, Operating Income, and Diluted EPS Within Range of Pre...

January 11, 2023, 11:45 am

Offshore fx broker threetrader becomes financial commission member

The Financial Commission (FinCom), a self-regulato...

January 11, 2023, 10:50 am

Fda approves astrazeneca's new treatment for people with asthma

AstraZeneca AZN, +0.99% AZN, -0.27% said Wednesday that the Food and Drug Administration approved a new...

January 11, 2023, 8:38 am

Umpqua holdings corporation announces $0.21 per common share dividend and date of fourth quarter 2022 earnings conference call

PORTLAND, Ore. , Jan. 11, 2023 /PRNewswire/ -- Umpqua Holdings Corporation (Nasdaq: UMPQ), parent company of Umpqua Bank, today announced that its boa...

January 11, 2023, 8:15 am

Volleyball empowerment sets record number of approved projects

The International Volleyball Federation (FIVB) has revealed that it has invested CHF 4 million (£3.6 million/$4.3 million/€4 million) in the cycle ...

January 10, 2023, 3:29 pm

Spirit airlines pilots approve new contract, lifting pay 34%

Nearly 70% of Spirit's pilots voted in favor of the deal, which the Air Line Pilots Association union said included gains worth $463 million. The two-...

January 10, 2023, 2:44 pm

Albireo pharma: elucidating the ipsen buyout (rating upgrade)

Albireo Pharma, Inc. has entered into an agreement to get acquired by Ipsen. Bylvay is already approved...

January 10, 2023, 2:19 pm

Abog approves aagl’s emigs training and testing program as option to meet surgical skills program standard

Dallas, Texas, Jan. 09, 2023 (GLOBE NEWSWIRE) — The American Board of Obstetrics and Gynecology (ABOG) has a...

January 9, 2023, 9:30 pm

Solid biosciences reports inducement grant to chief financial officer and treasurer

CHARLESTOWN, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for...

January 9, 2023, 9:26 pm

Novocure: catalysts stacking for more upside

Powered by the robust Phase 3 (LUNAR) trial, NovoCure Limited shares recently rallied over 70% in one trading session. You can expect Tumor Treating F...

January 9, 2023, 1:07 pm

Cymabay therapeutics announces collaboration with kaken pharmaceutical co., ltd. to develop and commercialize seladelpar in japan for primary biliary cholangitis

Advances strategy to partner seladelpar for PBC outside U.S. Brings in approximately $34.0 million upfront payment Japan represents an important marke...

January 8, 2023, 5:00 pm

Eisai files for full fda approval for alzheimer's drug leqembi

Japanese drugmaker Eisai Co Ltd said on Saturday it had submitted an application to the U.S. Food and Drug Administration for a standard review of its...

January 6, 2023, 11:42 pm


Search within

Pages Search Results: